Low-dose lithium reduces side effects from most common treatment for Parkinson's disease

(Buck Institute for Age Research) Low-dose lithium reduced involuntary motor movements -- the troubling side effect of the medication most commonly used to treat Parkinson's disease (PD) -- in a mouse model of the condition that is diagnosed in about 60,000 Americans each year. The third in a series of studies from the Andersen lab involving PD and low-dose lithium, the results add to mounting evidence that low-doses of the psychotropic drug could benefit patients suffering from the incurable, d...